# FDA Inspection 1266539 - Komal L. Jhaveri, M.D. - March 14, 2025

Source: https://www.keypedia.com/records/fda_inspections/komal-l-jhaveri-md/6a076ab3-9dd3-436d-9a25-a15cf6c70471
Source feed: FDA_Inspections

> FDA Inspection 1266539 for Komal L. Jhaveri, M.D. on March 14, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1266539
- Company Name: Komal L. Jhaveri, M.D.
- Inspection Date: 2025-03-14
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1266539 - 2025-03-14](https://www.keypedia.com/records/fda_inspections/komal-l-jhaveri-md/f506b1b2-5df8-41cc-8c23-f3ad942fdb31)
- [FDA Inspection 1245821 - 2024-07-26](https://www.keypedia.com/records/fda_inspections/komal-l-jhaveri-md/82699cb6-7dd5-4004-9f8e-34f1aeded761)

Company: https://www.keypedia.com/companies/komal-l-jhaveri-md/f6ed77e8-26b0-425b-a1f1-f595cf1ac374

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
